Key facts
- It has raised $7.5M; the latest was Seed Round ($2.5M) in Sep 2025.
- Notable investors include MassChallenge, Innovation Authority, Tech4Eva, Well4Tech, iXCore.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Imma Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Imma Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Imma Health
Developer of an ovarian stimulation monitoring system designed to solve the fertility crisis. The company's product includes a remote automated intravaginal ultrasound device with AI-powered image analysis and a dedicated app, enabling women to perform self-administered transvaginal scans in the comfort of their homes, thereby reducing clinic visits and associated stress.
- Sector
- Healthcare
- HQ
- Modi'in-Maccabim-Re'ut, Israel
- Founded
- 2021
- Employees
- 9
- Website
- imma.health/
- Ownership
- Privately Held (backing)
Imma Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Imma Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Imma Health in its N-PORT filings yet. We sweep new filings monthly.